| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC10338 | Bradykinin | Bradykinin is an active peptide that is generated by the kallikrein-kinin system. It is a inflammatory mediator and also recognized as a neuromediator and regulator of several vascular and renal functions. |
|
| DC40064 | Fasitibant chloride hydrochloride | Fasitibant chloride hydrochloride (MEN16132) is a potent, selective, high affinity, and longlasting nonpeptide bradykinin B2 (BK2)?receptor antagonist. Fasitibant chloride hydrochloride has?proinflammatory effects and can be used for the research of osteoarthritis and rheumatoid arthritis, et al. |
|
| DC41859 | Retrobradykinin | Retrobradykinin has the reverse sequence of Bradykinin. Retrobradykinin has no significant kinin activity and can be used as a negative control for Bradykinin. |
|
| DC42305 | Lys-[Des-Arg9]Bradykinin TFA | Lys-[Des-Arg9]Bradykinin TFA, a naturally occurring kinin, is a potent and highly selective bradykinin B1 receptor agonist with a Ki of 0.12 nM, 1.7 nM and 0.23 nM for human, mouse and rabbit B1 receptors, respectively. Lys-[Des-Arg9]Bradykinin TFA has lowy activity on B2 receptors. |
|
| DC42306 | [Hyp3]-Bradykinin | [Hyp3]-Bradykinin, naturally occurring peptide hormone, is a bradykinin receptor agonist. [Hyp3]-Bradykinin interacts with B2-bradykinin receptors and stimulates inositol phosphate production in cultured human fibroblasts. |
|
| DC48151 | Deucrictibant | Deucrictibant is a potent bradykinin receptor antagonist. Bradykinin receptors are cell surface, G-protein coupled receptors of the seven-transmembrane domained family. |
|
| DC71517 | Fulimetibant | Fulimetibant is a bradykinin receptor antagonist. |
|
| DC72185 | Bombinakinin M | Bombinakinin M is a bradykinin receptor agonist with contractile activity in the guinea pig ileum. |
|
| DC72881 | MEN 11270 | MEN 11270, a cyclic decapeptide, is a B2 kinin receptor antagonist. MEN 11270 bound with high-affinity to the B2 kinin receptor constitutively expressed by WI38 human fibroblasts, inhibiting 3H-bradykinin (BK) with pKi of 10.3. |
|
